Acadia Pharmaceuticals | ACAD - SCHULD

Aktienkurs
21.96
Täglich Wechseln
-0.15 -0.68%
Monatlich
-0.23%
Jährlich
49.08%
Q2 Prognose
21.49




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.36M 247K 2025-09
Cytokinetics USD 1.2B 338.79M 2025-09
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Incyte USD 40.41M 855K 2025-12
J&J USD 47.93B 2.14B 2025-12
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Pfizer USD 60.85B 78M 2025-09
Prothena USD 9.08M 699K 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09